GlobalData on MSN
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure
While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results